Admissions and Bed Days
Outcomes achieved using a digital service model for COPD
Admissions and bed days were both cut in half at 1 year survival in the RECEIVER group with these participants matched to a control reference population.
Let's look at what that means when considering how Lenus can transform the traditional COPD pathway.
Evidence stats
How the Lenus Service has reduced admissions and occupied bed days for users
-
49%
Reduction in admissions
-
4.74
Annual bed days saved per patient
Chart supplement
More information on the data visualised
| Control | RECEIVER | ||
|---|---|---|---|
| n | 315 | 69 | |
| Inclusion Criteria |
Control cohort criteria + alive for 12-months post-index date. |
RECEIVER cohort criteria + alive 12-months post-onboarding date. |
|
| Event Criteria | Occupied bed day (OBD) count from respiratory-related hospital admissions starting over a 12-month period. Year prior: OBDs from admissions starting between onboarding/index date and 365-days prior to this, Year following: admissions starting 1-day post- index/onboarding date and 365-days after this. | ||
- The annotated points show the mean number of occupied bed days had over each window with the distribution of values observed at each time point shown by the violin plots and overlaid boxplots.
- The reduction in OBDs seen in the control cohort has been widely reported across populations with COPD during the COVID-19 response period.
- Notably, a substantially higher reduction in OBDs was observed in the RECEIVER cohort and this reduction was controlled by comparing the mean difference in each cohort for year prior and year after.
Study details
ClinicalTrials.gov Identifier: NCT04240353
The feasibility and service adoption observational cohort RECEIVER trial was commenced in September 2019 by NHS Greater Glasgow and Clyde to evaluate the implementation and efficacy of the Lenus COPD Service with high-risk COPD participants matched 1:5 to a control cohort using de-identified contemporary routine clinical data. The protocol is published here with the full results available here.
| Control | RECEIVER | |||
|---|---|---|---|---|
| Inclusion Criteria |
Selected from the NHS Greater Glasgow and Clyde Safe Haven COPD dataset. Control cohort identification was conducted by iteratively identifying the individuals in the cohort who met the matching criteria for each RECEIVER participant. Duplicate control patients or individuals subsequently onboarded to Lenus COPD were excluded and then the optimal 5 matches for each RECEIVER participant were determined based on closest matches by age. The matching criteria were that matched individuals must: be alive at the onboarding date of the RECEIVER participant, be the same sex as the RECEIVER participant, and have had a COPD or respiratory related admission in the 7 days prior to the RECEIVER participant's onboarding date. |
At least one severe COPD exacerbation in the year prior to onboarding to Lenus COPD and/or chronic hypercapnic respiratory failure/sleep disordered breathing requiring NIV/CPAP treatment. | ||
| 1st Participant Index Date | 3rd September 2019 | |||
| Censor Date | 31st August 2021 | |||
| Total Patients | 415 | 83 | ||
NICE advice
Medtech Innovation Briefing
The National Institute of Health and Care Excellence (NICE) has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease available here.
Meet our experts
Get in touch if you would like to meet with our product or sales specialists. We'll be pleased to provide solution demonstrations and discuss pricing.
We are a Crown Commercial Service Supplier. Our solutions are on UK frameworks: G-Cloud 14, Spark DPS and AI DPS.
